{
    "table_name": "EBI_CHEMBL.PATENT_USE_CODES_33",
    "table_fullname": "EBI_CHEMBL.EBI_CHEMBL.PATENT_USE_CODES_33",
    "column_names": [
        "patent_use_code",
        "definition"
    ],
    "column_types": [
        "TEXT",
        "TEXT"
    ],
    "description": [
        null,
        null
    ],
    "sample_rows": [
        {
            "patent_use_code": "U-3315",
            "definition": "METHOD TO TREAT IDA IN ADULTS &amp; PEDIATRIC PATIENTS 1 YR &amp; OLDER WITH INTOLERANCE OR UNSATISFACTORY RESPONSE TO ORAL IRON &amp; WEIGHING AT LEAST 40 KG BY ADMINISTERING IV AT LEAST ABOUT 0.6 G OF IRON AS FERRIC CARBOXYMALTOSE IN ABOUT 15 MIN OR LESS"
        },
        {
            "patent_use_code": "U-3023",
            "definition": "TREATMENT OF CF IN PATIENTS 6 YEARS AND OLDER WHO HAVE A F508DEL OR G551D CFTR MUTATION AND A 2ND MUTATION SELECTED FROM R117H, A455E, 2789+5G-&gt;A, AND 3849+10KBC-&gt;T, COMPRISING CONCURRENT COADMINISTRATION OF THE COMPOSITIONS OF CLAIM 1 OF US 10058546"
        },
        {
            "patent_use_code": "U-3022",
            "definition": "TREATMENT OF CF IN PATIENTS 12 YEARS AND OLDER WHO HAVE A F508DEL OR G551D CFTR MUTATION AND A 2ND MUTATION SELECTED FROM R117H, A455E, 2789+5G-&gt;A, &amp; 3849+10KBC-&gt;T, COMPRISING CONCURRENT COADMINISTRATION OF THE COMPOSITIONS OF CLAIM 1 OF US 10058546"
        },
        {
            "patent_use_code": "U-228",
            "definition": "ASTHMA"
        },
        {
            "patent_use_code": "U-111",
            "definition": "DIABETES"
        }
    ]
}